How to Help Your Patients Find Prevymis in Stock: A Provider's Guide

In transplant medicine, continuity of CMV prophylaxis with Prevymis (letermovir) is a patient safety issue — not merely a convenience. Even a brief interruption in therapy can allow CMV to reactivate in immunocompromised patients, with potentially fatal consequences. Yet many patients leave the hospital without a clear plan for how to fill their prescription. This guide gives you concrete, actionable tools to help your patients find and fill Prevymis from day one.

Why Patients Struggle to Fill Prevymis

Most patients prescribed Prevymis at discharge will encounter one or more of the following barriers before they can fill their first outpatient prescription:

• Their regular pharmacy doesn't carry it (it's a specialty pharmacy-only drug)
• Their insurance requires prior authorization that hasn't been submitted yet
• They receive a denial requiring appeal, leading to multi-day delays
• The retail cost ($8,700+ per 30-day supply) is prohibitive without insurance or assistance
• They are confused about which form (tablet vs. pellet vs. IV) they are supposed to be taking

Step 1: Start the Process Before Discharge

The most impactful thing you can do is initiate the outpatient Prevymis prescription and prior authorization before the patient leaves the hospital. This means:

• Sending the Prevymis prescription to the designated specialty pharmacy at least 3-5 days before planned discharge
• Having your team submit prior authorization documentation proactively
• Confirming the patient has their insurance card and knows the specialty pharmacy name and phone number at discharge
• Providing the patient with enough inpatient supply (samples or hospital dispensed) to bridge any gap while outpatient insurance processes

Step 2: Choose the Right Specialty Pharmacy

Not all specialty pharmacies are equal in their ability to handle Prevymis, navigate payer criteria, and deliver quickly. Strong national options include:

• Accredo Specialty Pharmacy (Express Scripts) — One of the largest specialty pharmacies in the U.S.; experienced with transplant medications
• CVS Specialty — Nationwide network; strong prior auth support team; 24/7 pharmacist access
• Optum Specialty Pharmacy — Preferred by many UnitedHealth Group insurance plans; strong oncology/transplant capabilities
• Hospital-based specialty pharmacy — If your institution has its own specialty pharmacy, it may be the most seamless choice for your transplant patients

Step 3: Build a Discharge Checklist for Prevymis Patients

Consider creating a standardized discharge checklist for any patient being sent home on Prevymis. Include:

• Prevymis prescription sent to [named specialty pharmacy]
• Prior authorization submitted/approved — expiration date noted
• Merck savings card offered to commercially insured patients
• Merck Access Program enrollment initiated for uninsured/underinsured patients
• Bridge supply dispensed (if applicable) to cover any gap while PA processes
• Patient has specialty pharmacy contact number and knows to call if there are any delays

Step 4: Give Patients a Tool to Find Prevymis Locally

For patients who need a local pharmacy rather than mail-order, medfinder is a service that contacts pharmacies by phone to check which ones can fill a specific prescription and texts results back to the patient. This is particularly useful for Prevymis, where online pharmacy inventory systems typically don't reflect real-time specialty drug stock. Direct patients to medfinder.com at discharge.

Step 5: Proactively Manage Refills

HSCT patients need Prevymis for at least 100 days post-transplant (often extended to 200 days for high-risk patients). Kidney transplant patients need it for up to 200 days. This means multiple refill cycles — each requiring the PA to remain valid. Consider a clinical pharmacist review of all Prevymis patients at the 90-day mark to confirm the next refill is ready and PA hasn't lapsed.

Key Takeaway for Transplant Teams

Access to Prevymis is a systems problem, not a supply problem. The medication exists — it just requires coordinated effort to get it to the patient before gaps in prophylaxis occur. A pre-discharge specialty pharmacy workflow, early PA submission, and patient-facing resources like medfinder are the most effective tools. For a deeper look at the clinical landscape, see: Prevymis Shortage: What Providers Need to Know in 2026.